NVOON
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Ime in priimekNVOON
UvrstitevNo.1597
Tržna kapitalizacija$0.00
Popolnoma razredčena tržna kapitalizacija$0.00
Tržni delež%
Volumen trgovanja/tržna kapitalizacija (24h)1,362.99%
Razpoložljivi obtok55,532.20632617
Največja ponudba0
Skupna ponudba55,532.20632617
Hitrost kroženja%
Datum izdaje--
Cena, po kateri je bilo sredstvo prvič izdano--
Najvišja vrednost vseh časov64.27358143874574,2026-01-23
Najnižja cena35.899696845669084,2026-03-02
Javna veriga blokovETH
UvodNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Panoga
Družbeni mediji
etfindex:mc_etfindex_sourceOmejitev odgovornosti: Podatke zagotavlja cmc in se ne smejo obravnavati kot naložbeni nasveti.